Topic Review
NF-κB Pathway Inhibitors in Alzheimer’s Disease Treatment
The NF-κB family is a group of transcription factors that play a pivotal role in regulating various biological processes, including immune responses, inflammation, cell survival, and cellular differentiation. The involvement of the NF-κB pathway in immune system responses, inflammation, oxidative stress, and neuronal survival highlights its significance in Alzheimer’s disease (AD) progression.
  • 216
  • 25 Sep 2023
Topic Review
Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression
Sparse and conflicting evidence exists regarding the localization, expression, and regulation of phase II drug-metabolizing enzymes and drug transporters across gestational stages. To resolve the uncertainties and assumptions in current knowledge, additional pharmacokinetic (PK) data and clinical pharmacology research are required to understand drug metabolism and transport in the pregnant woman and in the placenta.
  • 216
  • 29 Dec 2023
Topic Review
Metabolism and Chemical Degradation of Glutides and Gliflozins
The drug metabolism and drug degradation pathways may overlap, resulting in the formation of similar constituents. Therefore, the metabolism data can be helpful for deriving safe levels of degradation impurities and improving the quality of respective pharmaceutical products. The entry contains considerations on possible links between metabolic and degradation pathways for new antidiabetic drugs such as glutides, gliflozins, and gliptins. Special attention was paid to their reported metabolites and identified degradation products. At the same time, many interesting analytical approaches to conducting metabolism as well as degradation experiments were mentioned, including chromatographic methods and radioactive labeling of the drugs. 
  • 215
  • 04 Aug 2023
Topic Review
Chemical Structures and Biological Activities of of Aplysinopsins
Marine products are among the most promising sources of biologically active molecules. Aplysinopsins, tryptophan-derived marine natural products, were isolated from different natural marine sources including sponges, stony corals (hard corals) especially genus scleractinian, as well as sea anemone, in addition to one nudibranch. Aplysinopsins were reported to be isolated from different marine organisms related to various geographic areas such as Pacific, Indonesia, Caribbean, and Mediterranean regions.
  • 214
  • 09 May 2023
Topic Review
Enhanced Drug Penetration and Retention in Airway Mucosa
Airway mucus is a complex viscoelastic gel mainly composed of water, glycoproteins, lipids, enzymes, minerals, etc. Among them, glycoprotein is the main factor determining mucus-gel-like rheology. Airway mucus forms a protective barrier by secreting mucin, which represents the absorption barrier, especially for more lipophilic drugs. It rapidly clears the drug from the airways through physiological mucus clearance mechanisms, so the drug does not remain in the lungs or reach the airway epithelial tissue for a long time.
  • 212
  • 08 Nov 2023
Topic Review
URAT1 and Other UA Transporters with Metabolic Syndrome
Urate transporter 1 (URAT1), which is a urate anion exchanger that regulates serum uric acid (UA) levels in the human kidney, was identified in 2002, and it has been targeted by uricosuric agents. In humans, renal reabsorption of UA into the blood plays an important role in controlling serum UA levels. The UA exchange is mediated by various molecules expressed in the renal proximal tubule. UA enters the proximal tubule epithelial cells in exchange for monocarboxylate via apical URAT1 and for dicarboxylate via the apical organic anion transporter (OAT) 4. OAT1 and OAT3 on the basolateral membrane of epithelial cells transport UA from the renal interstitial into the renal proximal tubule epithelial cells. Renal UA reabsorption is mainly mediated by URAT1 and glucose transporter 9 (GLUT9). Apical GLUT9b plays a significant role in UA reabsorption; the reabsorbed UA exits the proximal tubule epithelial cells into the blood through basolateral GLUT9a. The ATP-binding cassette transporter G2 (ABCG2) has been identified as a high-capacity UA exporter that mediates renal and/or extra-renal (intestinal) UA excretion.
  • 212
  • 27 Mar 2024
Topic Review
Curcumin Inorganic Nanoparticles and its Anti-cancer Potential
Curcumin is a natural compound that has been widely investigated thanks to its various biological properties, including antiproliferative. This molecule acts on different cancers such as lung, breast, pancreatic, colorectal, etc. However, the bioactive actions of curcumin have limitations when its physicochemical properties compromise its pharmacological potential. As a therapeutic strategy against cancer, curcumin has been associated with inorganic nanoparticles. These nanocarriers are capable of delivering curcumin and offering physicochemical properties that synergistically enhance anticancer properties. 
  • 211
  • 31 Jan 2024
Topic Review
Cyclodextrins and Their Derivatives as Drug Stability Modifiers
Cyclodextrins (CDs) are versatile excipients that are widely used in the pharmaceutical industry as receptor molecules to form complexes with drugs. CDs are cyclic oligosaccharides composed of α-1,4-linked D-glucopyranoside subunits obtained through enzymatic starch degradation.
  • 207
  • 09 Aug 2023
Topic Review
Prebiotic Boron-Containing Compounds in Complex Regional Pain Syndrome
Studies have demonstrated that individuals with complex regional pain syndrome (CRPS) often exhibit dysbiosis, with imbalances in beneficial and pathogenic gut bacteria. Dysbiosis can lead to increased gut permeability and systemic inflammation, contributing to the chronic pain experienced in CRPS. B, an essential trace element, has shown promise in modulating the gut microbiome positively and exerting anti-inflammatory effects. Preclinical and clinical studies suggest that B supplementation may alleviate neuropathic pain and improve CRPS symptoms by restoring microbiota balance and reducing inflammation. 
  • 208
  • 21 Nov 2023
Topic Review
Cannabis for Potential Therapeutic Uses
Cannabis sativa has been utilized as a medicine and for recreational and spiritual purposes. Phytocannabinoids are a family of compounds that are found in the cannabis plant, which is known for its psychotogenic and euphoric effects; the main psychotropic constituent of cannabis is Δ9-tetrahydrocannabinol (Δ9-THC). The pharmacological effects of cannabinoids are a result of interactions between those compounds and cannabinoid receptors, CB1 and CB2, located in many parts of the human body. Cannabis is used as a therapeutic agent for treating pain and emesis. Some cannabinoids are clinically applied for treating chronic pain, particularly cancer and multiple sclerosis-associated pain, for appetite stimulation and anti-emesis in HIV/AIDS and cancer patients, and for spasticity treatment in multiple sclerosis and epilepsy patients. Medical cannabis varies from recreational cannabis in the chemical content of THC and cannabidiol (CBD), modes of administration, and safety. Despite the therapeutic effects of cannabis, exposure to high concentrations of THC, the main compound that is responsible for most of the intoxicating effects experienced by users, could lead to psychological events and adverse effects that affect almost all body systems, such as neurological (dizziness, drowsiness, seizures, coma, and others), ophthalmological (mydriasis and conjunctival hyperemia), cardiovascular (tachycardia and arterial hypertension), and gastrointestinal (nausea, vomiting, and thirst), mainly associated with recreational use. Cannabis toxicity in children is more concerning and can cause serious adverse effects such as acute neurological symptoms (stupor), lethargy, seizures, and even coma. 
  • 200
  • 29 Feb 2024
  • Page
  • of
  • 106
Video Production Service